#weight-loss-drugs

As GLP-1 medications surge in popularity for weight loss, users report an unexpected side effect that's not quite depression - a troubling emotional numbness that's raising questions about the true cost of pharmaceutical weight management.

While Novo Nordisk's stock plummets 17% on weak 2026 outlook, Eli Lilly soars 8% with explosive growth. The weight loss drug market crown is changing hands as scale trumps innovation.